BioClad®’s high quality products and unprecedented levels of service has led them to form lasting relationships with several international high street brands, including McDonald’s, Starbucks and Virgin Atlantic. Furthermore, they has been awarded the NHS Supply Chain Innovation Award due to their continued work in UK’s hospitals and the healthcare industry. They also received a Queen’s Award for Enterprise in the International Trade category, which was officially announced in April 2017.
Benefiting from in-built BioCote® antimicrobial technology, antimicrobial wall cladding panels found in BioClad®’s portfolio are designed to combat bacteria and other microbes to uphold a fully hygienic environment. Their BioCote® protected range includes wall and door protection, flooring, IPS units and the world’s first, proven antimicrobial PVC hygienic wall cladding. All are ideal for environments where hygiene is paramount.
Every BioClad® product protected with BioCote® is independently tested to ensure its continued efficacy in reducing levels of bacteria such as MRSA, E. coli, Legionella, Salmonella, Aspergillus niger and mould by up to 99.99%. BioClad® adheres to the leading industry accreditations and is ISO 9001, 14001, 18001, CHAS & Constructionline accredited. It also complies with all relevant UK Law, the requirements of BSOHSAS 1800 and with NHS Estates Technical Memorandum (HTM)56.